Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Work ; 47(3): 399-412, 2014 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-24463318

RESUMO

BACKGROUND: In many western countries individuals will need to continue their professional careers beyond the current retirement age. This requires adaptation of the working conditions to compensate for age related visual changes. OBJECTIVE: The aim of this paper is to compile and structure knowledge concerning age related changes in visual and non-visual functions among older-age workers and to describe in what way these changes relate to light and work performance. METHOD: An overview of the literature was performed in PubMed and EMBASE concerning visual changes among elderly people, light, visual ergonomics and consequences at work. RESULTS: Visual conditions and lighting design have an impact on work performance in those over age 65 even if there are few studies available. Natural age related changes in the eyes or ocular diseases can result in reduced visual function and performance. Moreover, evidence of the importance of light and dark rhythms for circadian regulation is mounting; there are indications that the older-age population might need specific attention related to this issue. Finally, visual deteriorations might also, secondarily, induce strained postures and musculoskeletal symptoms, pain and injury. CONCLUSION: Age-related changes in the eyes and also ocular diseases among older-age people have an impact on well-being and work performance, and therefore call for reconsideration of their working conditions. Knowledge about how visual functions, light and ocular diseases is needed for work design and preventive actions.


Assuntos
Envelhecimento/fisiologia , Oftalmopatias , Iluminação , Visão Ocular/fisiologia , Ritmo Circadiano/fisiologia , Oftalmopatias/complicações , Oftalmopatias/fisiopatologia , Ofuscação , Humanos , Dor Musculoesquelética/etiologia , Postura , Testes Visuais , Acuidade Visual , Local de Trabalho
2.
Acta Paediatr ; 92(3): 301-8, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12725544

RESUMO

AIM: To investigate associated neurological, endocrinological and cognitive dysfunctions in children with visual impairment caused by optic nerve hypoplasia or optic nerve/fundus coloboma and/or microphthalmus. METHODS: Forty children born between 1990 and 1998 were assessed by neurological examination, re-evaluation of neuroradiological investigations, review of medical records and examination of cognitive levels. RESULTS: Neurological dysfunctions (epilepsy and/or motor impairment) were found in 13/28 children with optic nerve hypoplasia and in 3/12 children with coloboma/microphthalmus. The optic pathways were thin in 22/24, an abnormal posterior pituitary gland and/or thin infundibulum was found in 16/22 and absence of septum pellucidum in 14/27 children with optic nerve hypoplasia. Other types of cerebral abnormalities occurred in 9/26 children. Among children with coloboma/microphthalmus, the optic pathways were thin in 4/8 children but none had pituitary or cerebral midline abnormalities. Sixteen children with optic nerve hypoplasia were receiving hormone substitution but none of the children with coloboma/microphthalmus. Thirteen of the 16 children with optic nerve hypoplasia and with an abnormal pituitary region had endocrinological deficiencies. Mental retardation was found in 9/24 of the children with optic nerve hypoplasia and in 5/10 of the children with coloboma/microphthalmus. CONCLUSION: Endocrinological. neurological and neuroradiological defects seem more common in children with optic nerve hypoplasia than in children with coloboma. A pituitary region that appears abnormal in magnetic resonance imaging seems to predict endocrinological deficits in children with optic nerve hypoplasia.


Assuntos
Cegueira/etiologia , Transtornos Cognitivos/complicações , Coloboma/complicações , Doenças do Sistema Endócrino/complicações , Anormalidades do Olho/complicações , Hipoglicemia/congênito , Hipoglicemia/complicações , Microftalmia/complicações , Doenças do Sistema Nervoso/complicações , Doenças do Nervo Óptico/congênito , Doenças do Nervo Óptico/complicações , Cegueira/diagnóstico por imagem , Cegueira/patologia , Criança , Pré-Escolar , Transtornos Cognitivos/diagnóstico por imagem , Transtornos Cognitivos/patologia , Coloboma/diagnóstico por imagem , Coloboma/patologia , Doenças do Sistema Endócrino/diagnóstico por imagem , Doenças do Sistema Endócrino/patologia , Anormalidades do Olho/diagnóstico por imagem , Anormalidades do Olho/patologia , Feminino , Humanos , Hipoglicemia/diagnóstico por imagem , Lactente , Recém-Nascido , Masculino , Microftalmia/diagnóstico por imagem , Microftalmia/patologia , Doenças do Sistema Nervoso/diagnóstico por imagem , Doenças do Sistema Nervoso/patologia , Neurorradiografia , Doenças do Nervo Óptico/diagnóstico por imagem , Fatores de Risco , Índice de Gravidade de Doença
3.
Epidemiol Infect ; 127(1): 121-7, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11561964

RESUMO

To estimate the burden of disease due to congenital toxoplasmosis in Sweden the incidence of primary infections during pregnancy and birth prevalence of congenital toxoplasmosis in 40,978 children born in two regions in Sweden was determined. Women possibly infected during pregnancy were identified based on: 1, detection of specific IgG based on neonatal screening of the phenylketonuria (PKU) card blood spot followed by retrospective testing of stored prenatal samples to detect women who acquired infection during pregnancy and follow up of their children to 12 months: 2, detection of specific IgM on the PKU blood spot. The birth prevalence of congenital toxoplasmosis was 0.73/10,000 (95 % CI 0.15-2.14) (3/40,978). The incidence of primary infection during pregnancy was 5.1/10,000 (95% CI 2.6-8.9) susceptible pregnant women. The seroprevalence in the southern part was 25.7% and in the Stockholm area 14.0%. The incidence of infection during pregnancy was low, as the birth prevalence of congenital toxoplasmosis. Neonatal screening warrants consideration in view of the low cost and feasibility.


Assuntos
Toxoplasmose Congênita/epidemiologia , Algoritmos , Feminino , Humanos , Imunoglobulina G/sangue , Incidência , Recém-Nascido , Gravidez , Diagnóstico Pré-Natal , Suécia/epidemiologia , Toxoplasmose Congênita/diagnóstico
4.
Acta Paediatr ; 88(6): 667-70, 1999 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10419255

RESUMO

The aim of this prospective study was to define the incidence of congenital toxoplasmosis in Sweden. Blood eluates collected on filter papers, Guthrie cards, from 40978 newborn babies were analysed for specific immunoglobulin M (IgM) and IgG antitoxoplasma antibodies. This is a preliminary report of three children with congenital toxoplasmosis, defined by the occurrence of antitoxoplasma-specific IgM antibodies. Two children were asymptomatic at birth. They were both normally developed at the age of 12 and 15 months, respectively. The third child had unidentified but uncomplicated symptoms of infection in the neonatal period. As a result of the screening congenital toxoplasmosis was confirmed and treatment instituted. Microphthalmus and peripheral chorioretinitis were detected in one eye. In spite of the chemotherapeutic treatment he developed hydrocephalus needing neurosurgical intervention at the age of 3 months. His development at 14 months was normal. The incidence in Sweden of congenital toxoplasmosis detected by specific IgM antitoxoplasma antibodies in blood from filter papers is less than 1:10000.


Assuntos
Toxoplasmose Congênita/diagnóstico , Toxoplasmose Congênita/epidemiologia , Antibacterianos/uso terapêutico , Anticorpos Antiprotozoários/imunologia , Derivações do Líquido Cefalorraquidiano , Pré-Escolar , Oftalmopatias/diagnóstico , Feminino , Humanos , Hidrocefalia/cirurgia , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Recém-Nascido , Masculino , Estudos Prospectivos , Estudos Soroepidemiológicos , Espiramicina/uso terapêutico , Suécia/epidemiologia , Fatores de Tempo , Toxoplasmose Congênita/tratamento farmacológico , Toxoplasmose Congênita/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...